The chemotherapy of rodent malaria. LXI. Drug combinations to impede the selection of drug resistance, part 4: the potential role of 8-aminoquinolines

By Peters W.   Stewart L. B.   Robinson B. L.  

Annals of Tropical Medicine and Parasitology, Vol. 97, Iss. 3, 2003-04 ,pp. : 221-236

Maney Publishing

Access to resources Recommend Favorite

The chemotherapy of rodent malaria. LVII. Drug combinations to impede the selection of drug resistance, part 1: which model is appropriate?

By Peters W.  

Annals of Tropical Medicine and Parasitology, Vol. 93, Iss. 6, 1999-09 ,pp. : 569-587

Routledge Ltd

Access to resources Recommend Favorite

The chemotherapy of rodent malaria. LXII. Drug combinations to impede the selection of drug resistance, part 5: rates of development of resistance to some inhibitors of folate metabolism and to artesunate

By Stewart L.B.   Peters W.   Robinson B.L.  

Annals of Tropical Medicine and Parasitology, Vol. 98, Iss. 8, 2004-12 ,pp. : 763-783

Maney Publishing

Access to resources Recommend Favorite

Efficacy of Triplet Combination Chemotherapy with Oxaliplatin, Irinotecan and Capecitabine (OCX) in Metastatic Colorectal Cancer in Relation to RAS/RAF Mutation Status: Results of a Retrospective Analysis

By  

Oncology Research and Treatment, Vol. 37, Iss. 11, 2014-10 ,pp. : 646-652

Karger

Access to resources Recommend Favorite

Weak Linkage in parC of Neisseria Gonorrhea: Identification of Mutation Prone Point that can Lead to Drug Resistance

By Wiwanitkit Viroj  

Sexuality and Disability, Vol. 25, Iss. 2, 2007-06 ,pp. : 81-84

Springer Publishing Company

Access to resources Recommend Favorite